2 ASX stock picks with explosive potential

In return for more risk, you could buy some stocks that have catalysts just lined up over the next few years.

| More on:
Man with rocket wings which have flames coming out of them.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're willing to put up with a little bit more risk than the average, there are some ASX stocks out there with the capability to rocket in a short amount of time.

They potentially have some catalysts coming that, if they occur, could put an absolute rocket under the share price.

Of course, nothing is guaranteed, but enter these types of investments with an open mind and a risk-on mindset, and you may find yourself with handsome riches at the end of the journey.

Let's take a look at two ASX stock picks ripe with such potential:

Try a 1,400% gain for explosive potential

Telix Pharmaceuticals Ltd (ASX: TLX) shares, already up 15.8% so far this year, are a classic example of a growth stock with explosive capabilities.

It is a maker of anti-cancer diagnostic and therapeutic products.

This means that every success in the development process — clinical trials, regulatory approval, or commercial release — will be met with excitement in the stock market.

Its journey over the past few years is testament to that. The Telix share price has gained an unbelievable 1,468% in the past five years and 87% over the past 12 months.

The company is in a great position now because it already has a product, Illuccix, on sale commercially. So this brings in revenue to fund its future pipeline.

Many experts agree that Telix stocks have incredible potential. According to CMC Invest, all eight analysts studying the stock rate it as a buy.

The stock pick that could rocket with the economy

Chrysos Corporation Ltd (ASX: C79) has a very specific remit.

The company provides assay services for the mining industry, which means it tests samples to determine the quality and quantity of any minerals present.

Its PhotonAssay technology is unique in the industry for its speed, accuracy, and environmental credentials. And it is rapidly gaining customers.

That's shown in how the shares soared 77%  over the past year, during a period in which the mining industry has had mixed fortunes.

So imagine how well the business and stock could do when the mining industry is in full swing in the coming years as the global economy recovers back to health.

The shares have dipped 16% this year, providing a buying opportunity.

Shaw and Partners senior investment advisor Jed Richards attributed that to Chrysos falling short of revenue expectations in a January update.

But that's a minor setback, as far as he's concerned.

"Delays in the number of PhotonAssay unit installations reflect timing issues as opposed to a reduction in demand," Richards told The Bull.

"We view the share price reaction as overdone, presenting attractive entry levels for investors."

Motley Fool contributor Tony Yoo has positions in Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Chrysos and Telix Pharmaceuticals. The Motley Fool Australia has positions in and has recommended Chrysos. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A woman shows her phone screen and points up.
Growth Shares

2 ASX shares showing 'strong growth' that offer value right now

This pair of quality stocks have upward momentum that can't be denied right now, rising 38% and 15% since the…

Read more »

A young boy sits on his father's shoulders as they flex their muscles at sunrise on a beach
Growth Shares

I'd buy these great ASX growth shares in March

Growth stocks could achieve strong returns.

Read more »

A woman smiles as she sits on the bus using her phone and listening to music through headphones.
Growth Shares

1 ASX stock I think is just as hot as Nvidia (without all the hype)

There is an Australian business going as well as the US chip maker. Check this out.

Read more »

Happy man working on his laptop.
Growth Shares

1 ASX growth stock down 40% to buy right now

Goldman Sachs thinks this beaten down stock could be great value.

Read more »

A woman holds a tape measure against a wall painted with the word BIG, indicating a surge in gowth shares
Growth Shares

Goldman Sachs says these ASX growth shares are destined for big things

There's a reason Goldman has slapped buy ratings on these shares.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Growth Shares

A hot ASX stock with 'multiple catalysts' looming is 8% down. Time to buy

The Blackwattle team is still bullish on these pharmaceutical shares despite a recent sell-off.

Read more »

A happy boy with his dad dabs like a hero while his father checks his phone.
Growth Shares

2 ASX 200 growth shares to buy with 'immense opportunity' ahead

This pair is already going gangbusters, but imagine what would happen when interest rates flatten out then come down.

Read more »

A man sees some good news on his phone and gives a little cheer.
Growth Shares

Brokers say these explosive ASX growth shares are buys with massive upside

Big returns could be on the cards for owners of these shares.

Read more »